Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2012; 107(05): 1003-1005
DOI: 10.1160/TH11-11-0799
DOI: 10.1160/TH11-11-0799
Letters to the Editor
The homozygous p.C1024R-ADAMTS13 gene mutation links to a late-onset phenotype of Upshaw-Schulman syndrome in Japan
Financial support: This work was supported in part by research grants fro the Ministry of Health, Labor, and Welfare of Japan an the Ministry of Education, Culture, Sports, Science and Technology of Japan.
Further Information
Publication History
Received:
16 November 2011
Accepted after minor revision:
05 January 2011
Publication Date:
25 November 2017 (online)
-
References
- 1 Levy GG, Nichols WC, Lian EC. et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001; 413: 488-494.
- 2 Kremer-Hovinga J, Mäder G, Lovey P. et al. A second Swiss family with Upshaw-Schulman syndrome (hereditary thrombotic throbocytopenic purpura, TTP) : Clinical course and molecular findings. J Thromb Haemost. 2005; 03 (Suppl. 01) Abstarct P1139.
- 3 Tsai HM. Pathophysiology of thrombotic thrombocytopenic purpura. Int J Hematol 2010; 91: 1-19.
- 4 Hommais A, Rayes J, Houllier A. et al. Molecular characterization of four ADAMTS13 mutations responsible for congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome). Thromb Haemost 2007; 98: 593-599.
- 5 Furlan M, Lämmle B. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Wille-brand factor-cleaving protease. Best Pract Res Clin Haematol 2001; 14: 437-454.
- 6 Fujimura Y, Matsumoto M, Isonishi A. et al. Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan. J Thromb Haemost 2011; 09: 283-301.
- 7 Fujimura Y, Matsumoto M, Yagi H. et al. Von Wille-brand factor-cleaving protease and Upshaw-Schulman syndrome. Int J Hematol 2002; 75: 25-34.
- 8 Kato S, Matsumoto M, Matsuyama T. et al. Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity. Transfusion 2006; 46: 1444-1452.
- 9 Yagi H, Ito S, Kato S. et al. Plasma levels of ADAMTS13 antigen determined with an enzyme immunoassay using a neutralizing monoclonal antibody parallel ADAMTS13 activity LevEls. Int J Hematol 2007; 85: 403-407.
- 10 Ishizashi H, Yagi H, Matsumoto M. et al. Quantitative Western blot analysis of plasma ADAMTS13 antigen in patients with Upshaw-Schulman syndrome. Thromb Res 2007; 120: 381-386.
- 11 Tao Z, Anthony K, Peng Y. et al. Novel ADAMTS-13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura. J Thromb Haemost 2006; 04: 1931-1935.
- 12 Camilleri RS, Cohen H, Mackie IJ. et al. Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura. J Thromb Haemost 2008; 06: 331-338.